middle.news
Why Did Nexalis Therapeutics’ Losses Surge to $1.83M in 2025?
7:08pm on Friday 27th of February, 2026 AEDT
•
Healthcare
Read Story
Why Did Nexalis Therapeutics’ Losses Surge to $1.83M in 2025?
7:08pm on Friday 27th of February, 2026 AEDT
Key Points
Loss after tax increased to $1.83 million in 2025
Net tangible assets per share declined to negative 49 cents
Cash balance rose to $436,900 supported by equity and borrowings
Significant rise in product development and marketing expenses
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
NEXALIS THERAPEUTICS (ASX:NX1)
OPEN ARTICLE